Baining Yingchuang Secures Investment from Advantech Capital to Accelerate Development of High-End Perioperative Medical Devices

Jiangsu Baining Yingchuang Medical Technology Co., Ltd. (hereinafter referred to as “Baining Yingchuang”) has recently secured investment from ADDOR. The funds will be primarily allocated to the development of new products, the establishment of domestic and international sales teams, and professional marketing campaigns.

Jiangsu Baining Yingchuang Medical Technology Co., Ltd., established in 2018, is a national high-tech enterprise integrating the research and development, manufacturing, and sales of high-end medical devices related to the perioperative period. The company currently employs over 200 staff members, with its sales and R&D centers located in Nanjing, Jiangsu Province, and its production base situated in the Taizhou Medical High-Tech Zone, Jiangsu Province. The facility covers an area of 15,000 square meters and is equipped with Class 100,000 clean workshops, a Class 10,000 inspection and testing center, an animal experimentation center, and an environmental testing center. The company has been recognized as a Jiangsu Province “Specialized, Refined, Differential, and Innovative” Little Giant enterprise and a Jiangsu Province Potential Unicorn enterprise.

Jiangsu Baining Yingchuang Medical Technology Co., Ltd. specializes in the R&D and industrialization of high-end medical devices related to the perioperative period. The company boasts an R&D team composed of experienced domestic medical device development experts and clinical product application specialists. Currently, the company has structured its business around four major product lines: intraoperative neuromonitoring series, energy-based surgical instruments series, vacuum-assisted biopsy series, and sutures series. It has filed over 100 patents domestically and internationally, registered 20 trademarks, and obtained 25 registration certificates for Class II and Class III medical devices. Its representative products, including the "Intraoperative Neuromonitoring Series" and the "Ultrasonic Soft Tissue Cutting and Hemostasis System," are industry leaders. Notably, the "Intraoperative Neuromonitoring Navigation System" project won the Excellence Award at the 5th "China Chuangyi" Competition and was honored as a "National Excellent Innovation and Entrepreneurship Project" by the Ministry of Human Resources and Social Security.

Upon the completion of this round of financing, Jiangsu Baining Yingchuang Medical Technology Co., Ltd. will further increase its investment in R&D and production expansion, thereby strengthening the competitive advantage of its products. In the future, Baining Yingchuang will remain committed to its mission of “providing high-quality surgical products accessible to a broad patient population,” striving to build a premium Chinese brand in the field of surgical medical devices.

Huang Xiujuan, Founder of Jiangsu Baining Yingchuang Medical Technology Co., Ltd.It stated that it was a great honor to receive recognition from professional investment institutions, and that the development of Jiangsu Baining Yingchuang Medical Technology Co., Ltd. is inseparable from the trust and support of its partners. As a developer of high-end perioperative medical devices, Jiangsu Baining Yingchuang will continue to be guided by clinical needs and committed to patient benefits in the future, prioritizing innovation and efficiency while continuously improving its product portfolio in the field of surgery. In addition, while deeply cultivating the domestic market, the company is also actively exploring opportunities for Chinese-made medical devices to enter international markets, with the hope of bringing its high-quality surgical instruments to the world as soon as possible, thereby benefiting doctors and patients globally.

Xue Yi, Senior Partner at ADDORIt stated that the investment in Baining Yingchuang represents a strategic move by ADDOR in the field of surgical medical devices. As an emerging medical device company, Jiangsu Baining Yingchuang Medical Technology Co., Ltd. has obtained more than 20 Class II and Class III medical device registration certificates and achieved commercialization of multiple products within five years of its establishment. This demonstrates its high R&D efficiency and strong execution capability in commercialization. In particular, its product series represented by "intraoperative neuromonitoring" are among the leading domestic players in this niche segment, with excellent performance, reliable quality, and outstanding market performance. It is believed that as the company's future strategic layout is gradually implemented, Baining Yingchuang is highly likely to become a leading enterprise in China’s perioperative medical device sector.